Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood

S. Stick (Perth (WA), Australia)

Source: Virtual Congress 2020 – Respiratory diseases in children and adults
Session: Respiratory diseases in children and adults
Session type: Symposium
Number: 3795
Disease area: Paediatric lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Stick (Perth (WA), Australia). Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood. Virtual Congress 2020 – Respiratory diseases in children and adults

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018
Year: 2018



Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
Year: 2018



Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

From childhood to adulthood: growing up with a rare lung disease such as cystic fibrosis
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Cystic fibrosis lung disease – infancy to adulthood
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Elucidating progression of early cystic fibrosis lung disease
Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017
Year: 2017



Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002

Relations between the sinonasal development and the lung disease in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 103s
Year: 2005

Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014


Risk factors for early lung function decline in young children with Cystic Fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018



Predictive factors of lung function decline in adults with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 714s
Year: 2006

Questions of predicting and preventing the progression of pneumofibrosis in children with cystic fibrosis
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019

Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Risk factors associated with the development of interstitial lung abnormalities
Source: Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020
Year: 2021